Published in Ultrastruct Pathol on December 08, 1992
Licorice abuse: time to send a warning message. Ther Adv Endocrinol Metab (2012) 1.05
Potassium dependent rescue of a myopathy with core-like structures in mouse. Elife (2015) 0.77
Self-induced myopathy. Postgrad Med J (1997) 0.75
Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation (1997) 5.16
Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med (1989) 4.87
An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature (1989) 3.75
Correlating phenotype and genotype in the periodic paralyses. Neurology (2004) 2.55
Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy. Lancet (1995) 2.40
Cytochrome c oxidase deficiency in Leigh syndrome. Ann Neurol (1987) 2.20
Molecular characterization of a novel endonuclease (Xib) and possible involvement in lysosomal glycogen storage disorders. Exp Mol Pathol (1999) 2.09
Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol (1999) 1.95
Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology (1994) 1.83
Catecholamine-induced cardiomyopathy in multiple endocrine neoplasia. A histologic, ultrastructural, and biochemical study. Chest (1991) 1.82
Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology (1998) 1.79
Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. N Engl J Med (2001) 1.73
Cerebellar ataxia and coenzyme Q10 deficiency. Neurology (2003) 1.73
Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology (2001) 1.68
GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy. Neurology (2000) 1.64
The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ (2010) 1.63
A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. J Pediatr (1994) 1.59
Apoptotic features accompany acute quadriplegic myopathy. Neurology (2000) 1.57
Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care (1997) 1.52
Polyglucosan body disease. Muscle Nerve (1991) 1.50
Muscle MRI in female carriers of dystrophinopathy. Eur J Neurol (2012) 1.49
Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study. J Clin Pharmacol (1993) 1.45
Reversible dilated cardiomyopathy due to growth hormone deficiency. Am J Clin Pathol (1992) 1.44
Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology (1998) 1.42
Severe cardiopathy in branching enzyme deficiency. J Pediatr (1987) 1.41
Dicarboxylic acids and glucose utilization in humans: effect of sebacate. JPEN J Parenter Enteral Nutr (1994) 1.40
Effect of a vegetable-protein-rich polymeric diet treatment on body composition and energy metabolism in inactive Crohn's disease. Eur J Gastroenterol Hepatol (2000) 1.39
An 18-year-old woman with familial chylomicronaemia who would not stick to a diet. Lancet (1996) 1.37
Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am J Hum Genet (1990) 1.36
Heart-targeted overexpression of caspase3 in mice increases infarct size and depresses cardiac function. Proc Natl Acad Sci U S A (2001) 1.31
Domain organization of chicken gizzard myosin light chain kinase deduced from a cloned cDNA. Biochemistry (1986) 1.31
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes (1999) 1.31
Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies. Ann Neurol (1990) 1.28
Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism (2000) 1.27
Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis. J Clin Invest (1999) 1.25
Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis. Neuromuscul Disord (1997) 1.24
Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology (2007) 1.19
Metabolic causes of myoglobinuria. Ann Neurol (1990) 1.19
Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy. Am J Pathol (1988) 1.18
Widespread tissue distribution of a tRNALeu(UUR) mutation in the mitochondrial DNA of a patient with MELAS syndrome. Neurology (1991) 1.16
Differential diagnosis of fatal and benign cytochrome c oxidase-deficient myopathies of infancy: an immunohistochemical approach. Neurology (1991) 1.15
Fatty liver and drugs. Eur Rev Med Pharmacol Sci (2005) 1.15
Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care (1992) 1.15
Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother (2009) 1.14
Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol (1987) 1.13
Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy. Neurology (1998) 1.12
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol (2011) 1.11
Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. J Biol Chem (2000) 1.10
L-carnitine improves glucose disposal in type 2 diabetic patients. J Am Coll Nutr (1999) 1.10
Sterol carrier protein-2 is involved in cholesterol transfer from the endoplasmic reticulum to the plasma membrane in human fibroblasts. J Biol Chem (1995) 1.10
Myasthenia gravis during interferon alfa therapy. Neurology (1995) 1.10
Influence of chronic alcohol abuse on body weight and energy metabolism: is excess ethanol consumption a risk factor for obesity or malnutrition? J Intern Med (1998) 1.09
Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy. Pediatr Res (1990) 1.09
From functional to microvascular abnormalities in early diabetic retinopathy. Diabetes Metab Rev (1997) 1.08
Energy expenditure, substrate oxidation, and body composition in subjects with chronic alcoholism: new findings from metabolic assessment. Alcohol Clin Exp Res (1997) 1.07
Glycogen branching enzyme deficiency in adult polyglucosan body disease. Ann Neurol (1993) 1.07
A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q. Am J Hum Genet (1996) 1.07
Mitochondrial myopathies. J Inherit Metab Dis (1987) 1.06
Presence and further development of retinal dysfunction after 3-year follow up in IDDM patients without angiographically documented vasculopathy. Diabetologia (1994) 1.05
An Italian family with autosomal recessive inclusion-body myopathy and mutations in the GNE gene. Neurology (2002) 1.04
MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin Exp Immunol (1994) 1.04
Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects. Cell Death Differ (2006) 1.04
Benign reversible muscle cytochrome c oxidase deficiency: a second case. Neurology (1987) 1.04
Myotonic dystrophy: tissue-specific effect of somatic CTG expansions on allele-specific DMAHP/SIX5 expression. Hum Mol Genet (1999) 1.02
Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. Hum Gene Ther (1993) 1.01
Fatal infantile liver failure associated with mitochondrial DNA depletion. J Pediatr (1992) 1.01
Sex hormone-binding globulin levels and cardiovascular risk factors in morbidly obese subjects before and after weight reduction induced by diet or malabsorptive surgery. Atherosclerosis (2002) 1.01
A surgical option for familial chylomicronemia associated with insulin-resistant diabetes mellitus. Obes Surg (1998) 1.00
Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol (1995) 1.00
Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients. Blood (1998) 1.00
Clinical features associated with the A-->G transition at nucleotide 8344 of mtDNA ("MERRF mutation"). Neurology (1993) 0.99
Body composition and energy expenditure after weight loss following bariatric surgery. J Am Coll Nutr (2000) 0.99
Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism. Brain (2000) 0.98
Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. Chest (1996) 0.98
Expression of beta 1 integrin complexes on the surface of unfertilized mouse oocyte. Development (1993) 0.98
Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia (1997) 0.97
Identification of three novel mutations in non-Ashkenazi Italian patients with muscle phosphofructokinase deficiency. Am J Hum Genet (1994) 0.97
Neuromyopathy and restrictive cardiomyopathy with accumulation of intermediate filaments: a clinical, morphological and biochemical study. Acta Neuropathol (1991) 0.97
Chromosome 4q35 haplotypes and DNA rearrangements segregating in affected subjects of 19 Italian families with facioscapulohumeral muscular dystrophy (FSHD). Hum Genet (1994) 0.97
Epidermal growth factor, somatostatin, and psoriasis. Lancet (1983) 0.97
Incomplete penetrance in an SPG3A-linked family with a new mutation in the atlastin gene. Neurology (2004) 0.97
A late-onset mitochondrial myopathy is associated with a novel mitochondrial DNA (mtDNA) point mutation in the tRNA(Trp) gene. Neuromuscul Disord (1998) 0.97
Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology (1993) 0.96
Observations on the regulation of cell volume and metabolic control in vitro; changes in the composition and ultrastructure of liver slices under conditions of varying metabolic and transporting activity. J Membr Biol (1977) 0.95
Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients. Breast Cancer Res Treat (1988) 0.95
Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity. Atherosclerosis (2003) 0.95
A new mtDNA mutation associated with a progressive encephalopathy and cytochrome c oxidase deficiency. Neurology (2000) 0.94
Somatostatin in paroxysmal supraventricular and junctional tachycardia. Br Med J (Clin Res Ed) (1984) 0.94
Megaloblastic anemia due to folic acid deficiency after oral contraceptives. Haematologica (1979) 0.94
Spatial frequency-selective losses with pattern electroretinogram in type 1 (insulin-dependent) diabetic patients without retinopathy. Diabetologia (1990) 0.94
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. J Clin Gastroenterol (2000) 0.94
Nitric oxide synthases in normal and benign hyperplastic human prostate: immunohistochemistry and molecular biology. J Pathol (1999) 0.94
A woman who left her wheelchair. Lancet (1999) 0.93
Modulation of intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transport into rat bile. Biochem J (1996) 0.93
SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH. Cell Death Differ (2012) 0.93
Late onset lipid storage myopathy due to multiple acyl CoA dehydrogenase deficiency triggered by valproate. Neuromuscul Disord (1991) 0.93
Chronic taurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats. Amino Acids (2002) 0.92